Influenza Vaccine Study
Are you interested in participating in this clinical study?
Double-blinded, randomized, placebo-controlled, dose selection study in adults to assess the safety and immunogenicity of vaccines.
Inclusion criteria:
- Adults ≥65 years of age at the time of signing the informed consent.
- Participants who are medically stable. A stable medical condition is defined as a disease not requiring significant change in therapy or hospitalization for worsening disease during the 3 months prior to enrollment.
-
Written informed consent obtained from the participant prior to performing any protocol-related procedures.
-
Body mass index (BMI) < 35 kg/m² at screening.
Learn more:
Call us 786-772-0510
